EWING’S SARCOMA: APPROACHING CENTURY SINCE THIS BONE CANCER MADE NEWS
Author(s) -
Zehra Fadoo,
Mir Ibrahim Sajid
Publication year - 2019
Publication title -
journal of cancer and allied specialties
Language(s) - English
Resource type - Journals
ISSN - 2411-989X
DOI - 10.37029/jcas.v5i2.263
Subject(s) - ewing's sarcoma , sarcoma , cancer , medicine , bone sarcoma , pathology
Correspondence: Zehra Fadoo, Section of Pediatric Hematology/Oncology, Aga Khan University, Stadium Road, Karachi 74880, Pakistan. Email: zehra.fadoo@aku.edu A 100 years have gone by since James Stephen Ewing published the first edition of ‘Neoplastic Diseases: A TextBook on Tumours,’ in 1919.[1] This landmark publication formally laid down the foundations of the discipline of oncology. James Ewing’s contribution to modern-day oncological diagnosis and research has been immense. He cofounded the American Association for Cancer Research in 1907 and was its first president. He was also the first Professor of Pathology at Cornell and later became the director of Memorial Sloan-Kettering Cancer Center. In 1921, Ewing reported a new bone cancer and called it ‘a diffuse endothelioma of the bone.’ This discovery was later named after the maestro himself and since has been known to the world as Ewing’s sarcoma.[2,3]
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom